[
  {
    "ts": null,
    "headline": "Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know",
    "summary": "Amgen (AMGN) closed at $292.89 in the latest trading session, marking a -1.04% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=0dabcd2c4206360de43689c2adcfd8d49a5b567bcab9ac4c413f17ce3944d5ad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761256202,
      "headline": "Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know",
      "id": 137216498,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) closed at $292.89 in the latest trading session, marking a -1.04% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=0dabcd2c4206360de43689c2adcfd8d49a5b567bcab9ac4c413f17ce3944d5ad"
    }
  },
  {
    "ts": null,
    "headline": "Top Research Reports for Amazon.com, Wells Fargo & Amgen",
    "summary": "Amazon's AI push, Wells Fargo's post-cap growth, and Amgen's new drug momentum headline Zacks' latest top analyst reports.",
    "url": "https://finnhub.io/api/news?id=b52ca58c2eab7f68fff6328a69ba0de2fcc97f57dc929fe56ee9c546f9291306",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761252060,
      "headline": "Top Research Reports for Amazon.com, Wells Fargo & Amgen",
      "id": 137216183,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amazon's AI push, Wells Fargo's post-cap growth, and Amgen's new drug momentum headline Zacks' latest top analyst reports.",
      "url": "https://finnhub.io/api/news?id=b52ca58c2eab7f68fff6328a69ba0de2fcc97f57dc929fe56ee9c546f9291306"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Amgen Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=2527f94dd36c8a84452f13e6d46a503f091744c3287d0212582d486d8b333a07",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761237300,
      "headline": "Amgen Inc. stock underperforms Thursday when compared to competitors",
      "id": 137251849,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=2527f94dd36c8a84452f13e6d46a503f091744c3287d0212582d486d8b333a07"
    }
  },
  {
    "ts": null,
    "headline": "Viking Therapeutics Q3 Earnings: What We Learned (And Why We Should Keep Faith)",
    "summary": "Discover why Viking Therapeutics, Inc.'s VK2735 could lead GLP-1 obesity drugs. Click for my updated look at VKTX stock following its Q3 earnings release.",
    "url": "https://finnhub.io/api/news?id=81dffc518d7ac525fdbe0d394bcc51a1233cc19364ee4382fca7e75993e60008",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761216162,
      "headline": "Viking Therapeutics Q3 Earnings: What We Learned (And Why We Should Keep Faith)",
      "id": 137196831,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1192090097/image_1192090097.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Discover why Viking Therapeutics, Inc.'s VK2735 could lead GLP-1 obesity drugs. Click for my updated look at VKTX stock following its Q3 earnings release.",
      "url": "https://finnhub.io/api/news?id=81dffc518d7ac525fdbe0d394bcc51a1233cc19364ee4382fca7e75993e60008"
    }
  }
]